Biological Basis for Sleep Disturbance and Behavioral Symptoms in Dementia A Biobehavioral Model

被引:6
|
作者
Woods, Diana Lynn [1 ]
Phillips, Linda R. [1 ]
Martin, Jennifer L. [2 ,3 ]
机构
[1] Univ Calif Los Angeles, Sch Nursing, Ctr Adv Gerontol Nursing Sci, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Multicampus Program Geriatr Med & Gerontol, Los Angeles, CA 90095 USA
[3] Vet Affairs Greater Los Angeles Healthcare Syst, Ctr Geriatr Res Educ & Clin, Los Angeles, CA USA
关键词
NURSING-HOME RESIDENTS; MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E GENOTYPE; PITUITARY-ADRENAL AXIS; ALZHEIMERS-DISEASE; CORTISOL-LEVELS; PSYCHOLOGICAL SYMPTOMS; SALIVARY CORTISOL; INSTITUTIONALIZED PATIENTS; INDIVIDUAL-DIFFERENCES;
D O I
10.3928/19404921-20110302-01
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Behavioral symptoms and sleep disturbance occur in more than 56% of older adults with mild to moderate dementia and are challenging and costly. This article proposes a biobehavioral causal model to explain sleep disturbances and behavioral symptoms in dementia (BSD) based on an integrative science perspective using the life cycle model of stress (chronic stress) integrating genetic, neuroendocrine, and personality factors. The model proposes that: (a) BSD are an outcome of sleep disturbance; (b) hypothalamic-pituitary-adrenal (HPA) axis dysregulation is key to sleep disturbances and BSD; (c) genotype influences response to stress hormones; (d) HPA is influenced by genotype; (e) trait anxiety moderates the relationship between HPA axis and BSD and/or sleep disturbances; and (f) trait anxiety is influenced by genotype. Examining these relationships simultaneously will advance our theoretical understanding of BSD and sleep disturbances, potentially providing a basis for the design of targeted interventions and prevention strategies with an understanding of risk.
引用
收藏
页码:281 / 293
页数:13
相关论文
共 50 条
  • [21] Effect of yokukansan on the sleep disturbance of an animal model for cerebrovascular dementia
    Nogami, A.
    Takasaki, K.
    Nagao, M.
    Uchida, N.
    Sakata, Y.
    Katsurabayashi, S.
    Kubota, K.
    Mishima, K.
    Iwasaki, K.
    Nishimura, R.
    Fujiwara, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 139 - 140
  • [22] Effects of Yokukansan on the sleep disturbance of model rats for cerebrovascullar dementia
    Nogami, Ai
    Iwasaki, Katsunori
    Nagao, Masaki
    Takasaki, Kotaro
    Uchida, Naoki
    Kawasaki, Chihiro
    Yamaguchi, Kazuko
    Sakata, Yuri
    Ii, Miyuki
    Katsurabayashi, Syutaro
    Kubota, Kaori
    Mishima, Kenichi
    Nishimura, Ryoji
    Fujiwara, Michihiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 123P - 123P
  • [23] Somatic symptoms in sleep disturbance
    Nordin, Gustav
    Sundqvist, Robin
    Nordin, Steven
    Gruber, Michael
    PSYCHOLOGY HEALTH & MEDICINE, 2023, 28 (04) : 884 - 894
  • [24] Medications in Patients with Dementia and Behavioral Disturbance
    Zhong, Wenjun
    Liu, Xinyue
    Voss, Tiffini
    Khalilieh, Sauzanne
    Khandker, Rezaul Karim
    Bortnichak, Edward
    Liaw, Kai-Li
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2021, 5 (01) : 535 - 540
  • [25] Nonpharmacologic treatment of behavioral disturbance in dementia
    Teri, L
    Logsdon, RG
    McCurry, SM
    MEDICAL CLINICS OF NORTH AMERICA, 2002, 86 (03) : 641 - +
  • [26] Dopaminergic function in dementia with behavioral disturbance
    Sweet, RA
    Pollock, BG
    Mulsant, BH
    Rosen, J
    Lo, KH
    Yao, JK
    Henteleff, RA
    Mazumdar, S
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 523 - 523
  • [27] BEHAVIORAL DISTURBANCE IN DEMENTIA OF THE ALZHEIMERS TYPE
    TERI, L
    LARSON, EB
    REIFLER, BV
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1988, 36 (01) : 1 - 6
  • [28] Buspirone for the treatment of dementia with behavioral disturbance
    Santa Cruz, Maria R.
    Hidalgo, Priscilla C.
    Lee, Meredith S.
    Thomas, Cornelius W.
    Holroyd, Suzanne
    INTERNATIONAL PSYCHOGERIATRICS, 2017, 29 (05) : 859 - 862
  • [29] Impact of dementia on behavioral independence and disturbance
    Nakayama, Naoyuki
    Suzuki, Makoto
    Endo, Arisa
    Nitanda, Yusuke
    Tanabe, Nao
    Watanabe, Aki
    Fukuda, Michinari
    Endo, Teruaki
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2017, 17 (04) : 605 - 613
  • [30] Evaluation of risperidone in the treatment of behavioral and psychological symptoms and sleep disturbances associated with dementia
    Durán, JC
    Greenspan, A
    Diago, JI
    Gallego, R
    Martinez, G
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 (04) : 591 - 604